Hanne R. Hagland

University of Stavanger — Norway

Immunology and Microbiology · Life Sciences

19h-index1.4kcitations66works0.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Phagocytosis and Immune Regulation(12), Immunotherapy and Immune Responses(11), Colorectal Cancer Treatments and Studies(11), Genetic factors in colorectal cancer(11), Cancer, Hypoxia, and Metabolism(10)

Publications66 total

ASO Visual Abstract: Combined Impact of Neoadjuvant Therapy and Preoperative Cachexia on Patients Undergoing Pancreatoduodenectomy: Is There a “Double Jeopardy”? A National Cohort Study Investigating the Association with Short- and Long-Term Outcomes
Annals of Surgical Oncology·2026
The Dual Mechanism of Action of CO-005 Overcomes CD20 Resistance in Diffuse Large B-Cell Lymphoma
ImmunoTargets and Therapy·2026Open Access
Combined Impact of Neoadjuvant Therapy and Preoperative Cachexia in Patients Undergoing Pancreatoduodenectomy: Is There a “Double Jeopardy”? A National Cohort Study Investigating the Association with Short- and Long-Term Outcomes
Annals of Surgical Oncology·2026Open Access
Matrix composition and glucose availability cooperatively determine cancer spheroid bioenergetics in 3D hydrogels
Cancer & Metabolism·2025Open Access
Mechanical and cell attachment evaluation of additively manufactured biomimetic architected scaffolds for tissue engineering
Journal of the mechanical behavior of biomedical materials/Journal of mechanical behavior of biomedical materials·2025Open Access
Figure S5 from Development of a Novel Bifunctional Anti-CD47 Fusion Protein with Improved Efficacy and a Favorable Safety Profile
2025Open Access
Table S4 from Development of a Novel Bifunctional Anti-CD47 Fusion Protein with Improved Efficacy and a Favorable Safety Profile
2025Open Access
Figure S3 from Development of a Novel Bifunctional Anti-CD47 Fusion Protein with Improved Efficacy and a Favorable Safety Profile
2025Open Access
Figure S2 from Development of a Novel Bifunctional Anti-CD47 Fusion Protein with Improved Efficacy and a Favorable Safety Profile
2025Open Access
Figure S4 from Development of a Novel Bifunctional Anti-CD47 Fusion Protein with Improved Efficacy and a Favorable Safety Profile
2025Open Access
Table S1 from Development of a Novel Bifunctional Anti-CD47 Fusion Protein with Improved Efficacy and a Favorable Safety Profile
2025Open Access
Table S3 from Development of a Novel Bifunctional Anti-CD47 Fusion Protein with Improved Efficacy and a Favorable Safety Profile
2025Open Access
Data from Development of a Novel Bifunctional Anti-CD47 Fusion Protein with Improved Efficacy and a Favorable Safety Profile
2025Open Access
Figure S1 from Development of a Novel Bifunctional Anti-CD47 Fusion Protein with Improved Efficacy and a Favorable Safety Profile
2025Open Access
Table S2 from Development of a Novel Bifunctional Anti-CD47 Fusion Protein with Improved Efficacy and a Favorable Safety Profile
2025Open Access
Development of a Novel Bifunctional Anti-CD47 Fusion Protein with Improved Efficacy and a Favorable Safety Profile
Molecular Cancer Therapeutics·2025· 1 citedOpen Access
Patient-derived organoids from pancreatic cancer after pancreatectomy: Feasibility and organoid take rate in treatment-naïve periampullary tumors
Pancreatology·2024· 7 citedOpen Access
Establishing patient-derived organoids from pancreatectomy specimens in treatment-naïve periampullary tumors: feasibility, organoid yield and biobank procurement for ex vivo translational research in pancreatic cancer
Pancreatology·2024
Impact of the Graphene Production Methods Sonication and Microfluidization on <i>In Vitro</i> and <i>In Vivo</i> Toxicity, Macrophage Response, and Complement Activation
ACS Omega·2024Open Access
Comparing in vitro cytotoxic drug sensitivity in colon and pancreatic cancer using <scp>2D</scp> and <scp>3D</scp> cell models: Contrasting viability and growth inhibition in clinically relevant dose and repeated drug cycles
Cancer Medicine·2024· 11 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Kjetil Søreide(27), Martin Watson(13), Karl Johan Tronstad(13), Dordi Lea(12), Gro Vatne Røsland(6), Tia Tidwell(6), Abdelnour Alhourani(6), Sittana Matar(6), Seham Skah(6), Liza E. Diomande(6), Tim Buss(6), Rune J. Forstrøm(6), Bjørn Dalhus(6), Kjetil Hestdal(6), Rolf D. Pettersen(6), Nina Richartz(6), Julie Nikolaisen(5), Jon Arne Søreide(5), Ajay Yadav(5), Marianne Berg(4)